Table II.
Laboratory index | Reference values | Asymptomatic-moderate group (n=141) | Severe or above (n=29) | OR (95% CI) | P-value |
---|---|---|---|---|---|
WBC (x109/l) | 3.5-9.5 | 5.0±1.5 | 5.5±2.7 | 1.190 (0.937, 1.513) | 0.154 |
Neur (%) | 40.0-75.0 | 58.8±11.9 | 70.5±16.1 | 1.072 (1.026, 1.120) | 0.002 |
Lymr (%) | 20.0-50.0 | 30.4±11.1 | 21.1±12.6 | 0.935 (0.888, 0.985) | 0.012 |
Monr (%) | 3.0-8.0 | 9.6±3.2 | 7.5±3.7 | 0.762 (0.633, 0.916) | 0.004 |
Neuc (x109/l) | 1.8-6.3 | 3.0±1.3 | 4.1±2.8 | 1.375 (1.042, 1.815) | 0.025 |
Lymc (x109/l) | 1.1-3.2 | 1.5±0.7 | 1.0±0.5 | 0.300 (0.099, 0.911) | 0.034 |
Monc (x109/l) | 0.1-0.6 | 0.5±0.2 | 0.4±0.2 | 0.058 (0.003, 1.018) | 0.051 |
RBC (x1012/l) | Females, 3.8-5.1; males, 4.3-5.8 | 4.7±0.7 | 4.3±0.6 | 0.413 (0.148, 1.151) | 0.091 |
HGB (g/l) | Females, 115-150; males, 130-175 | 139.6±17.9 | 130.1±21.2 | 0.973 (0.946, 1.002) | 0.066 |
HCT (%) | Females, 35.0-45.0; males, 40.0-50.0 | 41.2±4.7 | 37.7±5.5 | 0.868 (0.775, 0.972) | 0.014 |
PLT (x109/l) | 125.0-350.0 | 184.3±58.5 | 173.9±56.5 | 1.006 (0.997, 1.015) | 0.173 |
RDW (%) | 11.5-14.9 | 13.1±1.9 | 13.6±2.8 | 1.191 (0.871, 1.629) | 0.274 |
MPV (fl) | 6.0-11.5 | 11.0±1.2 | 10.9±1.2 | 0.734 (0.467, 1.155) | 0.182 |
PDW (fl) | 15.5-18.1 | 14.8±3.2 | 15.3±2.1 | 0.980 (0.806, 1.192) | 0.840 |
PTC (l/l) | 0.108-0.272 | 0.2±0.1 | 0.2±0.1 | 0.904 (0.000, 10,957.021) | 0.983 |
hsCRP (mg/l) | 0.0-10.0 | 13.6±21.0 | 78.3±63.8 | 1.041 (1.020, 1.062) | <0.001 |
PCT (ng/ml) | 0.00-0.05 | 0.15±0.18 | 0.46±0.64 | 13.774 (1.399, 135.619) | 0.025 |
Adjusted variables: Age, sex, hypertension, diabetes mellitus, cerebrovascular diseases, history of the tumor. OR, odds ratio; WBC, white blood cells; Neur, percentage of neutrophils; Lymr, percentage of lymphocytes; Monr, percentage of monocytes; Neuc, neutrophil count; Lymc, lymphocyte count; Monc, monocyte count; RBC, red blood cell count; HGB, hemoglobin; HCT, hematocrit, PLT, platelet count; RDW, red blood cell distribution width; MPV, mean platelet volume; PDW, platelet distribution width; PTC, plateletcrit; hsCRP, high-sensitivity C-reactive protein; PCT, procalcitonin.